UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 89

Sortiert nach

Social and Economic Impact of Patients with Metastatic Breast Cancer in Brazil

Value in health, 2018-05, Vol.21, p.S26

2018

Volltextzugriff (PDF)

PCN83 - Social and Economic Impact of Patients with Metastatic Breast Cancer in Brazil

Value in health, 2018-05, Vol.21, p.S26-S26

2018

Volltextzugriff (PDF)

Economic Impact of Absenteeism and Deaths Due to Pneumonia in Brazilian Economy

Value in health, 2018-05, Vol.21, p.S233-S234

2018

Volltextzugriff (PDF)

PRS9 - Estimated Number of Deaths Due to Pneumonia in High Risk Patients According to Nip: A Retrospective Study in Brazilian Public Health

Value in health, 2018-05, Vol.21, p.S232-S232

2018

Volltextzugriff (PDF)

PRS22 - Economic Impact of Absenteeism and Deaths Due to Pneumonia in Brazilian Economy

Value in health, 2018-05, Vol.21, p.S233-S234

2018

Volltextzugriff (PDF)

Estimated Number of Deaths Due to Pneumonia in High Risk Patients According to Nip: A Retrospective Study in Brazilian Public Health

Value in health, 2018-05, Vol.21, p.S232

2018

Volltextzugriff (PDF)

PSY4 - Acromegaly Patients with Inadequate Response to Maximum Dose Octreotide-Lar Who Progress to Treatment with Pegvisomant: Economic Evaluation and Incremental Budget Impact Analysis from the Public Perspective to São Paulo State

Value in health, 2015-11, Vol.18 (7), p.A842-A842

2015

Volltextzugriff (PDF)

PRS4 - Public Health and Economic Impact of 13-Valent Pneumococcal Conjugate Vaccine (Pcv13) in Public and Private System Versus Ppsv23 and No Vaccination in Older Adults

Value in health, 2015-11, Vol.18 (7), p.A839-A839

2015

Volltextzugriff (PDF)

Análise De Impacto Orçamentário Do Axitinibe Na Segunda Linha De Tratamento Do Carcinoma De Células Renais Metastático Sob a Perspectiva Do Sistema Privado De Saúde Brasileiro

Value in health, 2017-10, Vol.20 (9), p.A872-A873

2017

Volltextzugriff (PDF)

PMS15 - Análise De Custo Minimização Na Substituição De Infliximabe Por Seu Biossimilar No Sistema De Saúde Suplementar Brasileiro

Value in health, 2017-10, Vol.20 (9), p.A937-A937

2017

Volltextzugriff (PDF)

IMPACTO ORÇAMENTÁRIO DA INCORPORAÇÃO DE TOFACITINIBE NO SISTEMA ÚNICO DE SAÚDE

Value in health, 2017-10, Vol.20 (9), p.A936

2017

Volltextzugriff (PDF)

PCN13 - Análise De Impacto Orçamentário Do Axitinibe Na Segunda Linha De Tratamento Do Carcinoma De Células Renais Metastático Sob a Perspectiva Do Sistema Privado De Saúde Brasileiro

Value in health, 2017-10, Vol.20 (9), p.A872-A873

2017

Volltextzugriff (PDF)

Análise De Impacto Orçamentário Do Crizotinibe No Tratamento Do Câncer De Pulmão Não Pequenas Células Avançado Alk-Positivo Sob a Perspectiva Do Sistema Privado De Saúde Brasileiro

Value in health, 2017-10, Vol.20 (9), p.A873

2017

Volltextzugriff (PDF)

PCN14 - Análise De Impacto Orçamentário Do Crizotinibe No Tratamento Do Câncer De Pulmão Não Pequenas Células Avançado Alk-Positivo Sob a Perspectiva Do Sistema Privado De Saúde Brasileiro

Value in health, 2017-10, Vol.20 (9), p.A873-A873

2017

Volltextzugriff (PDF)

Análise De Custo Minimização Na Substituição De Infliximabe Por Seu Biossimilar No Sistema De Saúde Suplementar Brasileiro

Value in health, 2017-10, Vol.20 (9), p.A937

2017

Volltextzugriff (PDF)

PMS10 - Impacto Orçamentário Da Incorporação De Tofacitinibe No Sistema Único De Saúde

Value in health, 2017-10, Vol.20 (9), p.A936-A937

2017

Volltextzugriff (PDF)

Impacto Orçamentário Da Incorporação De Tofacitinibe No Sistema Único De Saúde

Value in health, 2017-10, Vol.20 (9), p.A936-A937

2017

Volltextzugriff (PDF)

BUDGET IMPACT ANALYSIS OF CRIZOTINIB IN THE TREATMENT OF ALK-POSITIVE NON-SMALL CELL LUNG CANCER IN THE BRAZILIAN PRIVATE HEALTH SYSTEM

Value in health, 2017-05, Vol.20 (5), p.A97

2017

Volltextzugriff (PDF)

COST MINIMIZATION ANALYSIS IN THE SWITCH OF INFLIXIMAB FOR ITS BIOSIMILAR IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM

Value in health, 2017-05, Vol.20 (5), p.A147

2017

Volltextzugriff (PDF)

RETURN OVER INVESTIMENT ANALYSIS ON PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE CAMPAIGN IN PATIENTS OVER 50 YEARS IN BRAZILIAN PRIVATE HEALTHCARE

Value in health, 2017-05, Vol.20 (5), p.A74

2017

Volltextzugriff (PDF)

NUMBER OF TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY CASES IN BRAZIL

Value in health, 2017-05, Vol.20 (5), p.A212

2017

Volltextzugriff (PDF)

BUDGET IMPACT ANALYSIS OF AXITINIB IN THE TREATMENT OF METASTATIC RENAL CELL CARCINOMA AFTER THE FAILURE OF ONE PRIOR SYSTEMIC THERAPY IN THE BRAZILIAN PRIVATE HEALTH SYSTEM

Value in health, 2017-05, Vol.20 (5), p.A97

2017

Volltextzugriff (PDF)

Public Health and Economic Impact of 13-Valent Pneumococcal Conjugate Vaccine (Pcv13) in Public and Private System Versus Ppsv23 and No Vaccination in Older Adults

Value in health, 2015-11, Vol.18 (7), p.A839-A839

2015

Volltextzugriff (PDF)

Acromegaly Patients with Inadequate Response to Maximum Dose Octreotide-Lar Who Progress to Treatment with Pegvisomant: Economic Evaluation and Incremental Budget Impact Analysis from the Public Perspective to São Paulo State

Value in health, 2015-11, Vol.18 (7), p.A842-A842

2015

Volltextzugriff (PDF)

Death Burden Of Pneumococcal Disease On Brazilian Private Health System

Value in health, 2016-05, Vol.19 (3), p.A12-A12

2016

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(85)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(37)
Life Sciences & Biomedicine
(33)
Humans
(17)
Biological And Medical Sciences
(16)
Male
(15)
Oncology
(15)
Animals
(14)
Medical Sciences
(14)
Adolescent
(11)
Child
(11)
Internal Medicine
(11)
Female
(10)
Mice
(10)
Adult
(9)
Child, Preschool
(9)
Neoplasms - Drug Therapy
(9)
Pharmacology. Drug Treatments
(8)
Antineoplastic Agents
(7)
Camptothecin - Analogs & Derivatives
(7)
Topotecan - Pharmacokinetics
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Social and Economic Impact of Patients with Metastatic Breast Cancer in Brazil

PCN83 - Social and Economic Impact of Patients with Metastatic Breast Cancer in Brazil

Economic Impact of Absenteeism and Deaths Due to Pneumonia in Brazilian Economy

PRS9 - Estimated Number of Deaths Due to Pneumonia in High Risk Patients According to Nip: A Retrospective Study in Brazilian Public Health

PRS22 - Economic Impact of Absenteeism and Deaths Due to Pneumonia in Brazilian Economy

Estimated Number of Deaths Due to Pneumonia in High Risk Patients According to Nip: A Retrospective Study in Brazilian Public Health

PSY4 - Acromegaly Patients with Inadequate Response to Maximum Dose Octreotide-Lar Who Progress to Treatment with Pegvisomant: Economic Evaluation and Incremental Budget Impact Analysis from the Public Perspective to São Paulo State

PRS4 - Public Health and Economic Impact of 13-Valent Pneumococcal Conjugate Vaccine (Pcv13) in Public and Private System Versus Ppsv23 and No Vaccination in Older Adults

Análise De Impacto Orçamentário Do Axitinibe Na Segunda Linha De Tratamento Do Carcinoma De Células Renais Metastático Sob a Perspectiva Do Sistema Privado De Saúde Brasileiro

PMS15 - Análise De Custo Minimização Na Substituição De Infliximabe Por Seu Biossimilar No Sistema De Saúde Suplementar Brasileiro

IMPACTO ORÇAMENTÁRIO DA INCORPORAÇÃO DE TOFACITINIBE NO SISTEMA ÚNICO DE SAÚDE

PCN13 - Análise De Impacto Orçamentário Do Axitinibe Na Segunda Linha De Tratamento Do Carcinoma De Células Renais Metastático Sob a Perspectiva Do Sistema Privado De Saúde Brasileiro

Análise De Impacto Orçamentário Do Crizotinibe No Tratamento Do Câncer De Pulmão Não Pequenas Células Avançado Alk-Positivo Sob a Perspectiva Do Sistema Privado De Saúde Brasileiro

PCN14 - Análise De Impacto Orçamentário Do Crizotinibe No Tratamento Do Câncer De Pulmão Não Pequenas Células Avançado Alk-Positivo Sob a Perspectiva Do Sistema Privado De Saúde Brasileiro

Análise De Custo Minimização Na Substituição De Infliximabe Por Seu Biossimilar No Sistema De Saúde Suplementar Brasileiro

PMS10 - Impacto Orçamentário Da Incorporação De Tofacitinibe No Sistema Único De Saúde

Impacto Orçamentário Da Incorporação De Tofacitinibe No Sistema Único De Saúde

BUDGET IMPACT ANALYSIS OF CRIZOTINIB IN THE TREATMENT OF ALK-POSITIVE NON-SMALL CELL LUNG CANCER IN THE BRAZILIAN PRIVATE HEALTH SYSTEM

COST MINIMIZATION ANALYSIS IN THE SWITCH OF INFLIXIMAB FOR ITS BIOSIMILAR IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM

RETURN OVER INVESTIMENT ANALYSIS ON PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE CAMPAIGN IN PATIENTS OVER 50 YEARS IN BRAZILIAN PRIVATE HEALTHCARE

NUMBER OF TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY CASES IN BRAZIL

BUDGET IMPACT ANALYSIS OF AXITINIB IN THE TREATMENT OF METASTATIC RENAL CELL CARCINOMA AFTER THE FAILURE OF ONE PRIOR SYSTEMIC THERAPY IN THE BRAZILIAN PRIVATE HEALTH SYSTEM

Public Health and Economic Impact of 13-Valent Pneumococcal Conjugate Vaccine (Pcv13) in Public and Private System Versus Ppsv23 and No Vaccination in Older Adults

Acromegaly Patients with Inadequate Response to Maximum Dose Octreotide-Lar Who Progress to Treatment with Pegvisomant: Economic Evaluation and Incremental Budget Impact Analysis from the Public Perspective to São Paulo State

Death Burden Of Pneumococcal Disease On Brazilian Private Health System

Suchergebnisse filtern